Prescribing information available here
The Bufomix (budesonide/formoterol) Easyhaler® range delivers effective, well-tolerated, and affordable therapy for asthma and COPD care.
The maintenance and reliever therapy indication in asthma for all ages from 12 years allows flexible tailoring of therapy for patients. Bufomix Easyhaler® is certified carbon neutral and produced by Orion Pharma in Finland.1
Date of preparation: October 2022 / EASYH-2728
References
- Budesonide-formoterol Easyhaler 80/4.5, 160/4.5, and 320/9 mcg. SmPC. Orion Pharma.
DATE OF PREPARATION: MAY 2023/EASYH-688(10)
FULL PRESCRIBING INFORMATION AVAILABLE HERE
For more information about Orion and Sustainability click here
